Organization | Health Sciences North Research Institute

Health Sciences North Research Institute Report issue

Academic/Hospital Phase 4

Founded: Sudbury Canada (2011)

Organization Overview

First Clinical Trial

2014

NCT02297542

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2024

Timeline

NOW

Now

Alternative names

Health Sciences North | Health Sciences North Research Institute

Active Ingredients

Drugs in Phase 4 Trials (9)

epimorphine (1 trial)

epinephrine (levophed) (1 trial)

fentanyl (Innovar) (1 trial)

fluarix (1 trial)

inactivated influenza vaccine (1 trial)

ketorolac (acuvail) (2 trials)

levobupivacaine (chirocaine) (1 trial)

ropivacaine (naropin) (1 trial)

sodium chloride (1 trial)

Drugs in Other Trials (2)

ibuprofen (motrin) (1 trial)

metoclopramide (reglan) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Influenza, Human (Phase 4)

Overview

Highest Phase: Phase 4
# of Trials: 4
# of Trial APIs: 11